Mel Medical Enterprises is seeking a medical distributor in Australia with expertise and experience supporting devices in the field of urology.
Mel Medical Enterprises has designed a device and special catheters for the treatment of non-muscle invasive bladder cancer.
The Synergo device uses Radiofrequency-Induced Thermochemotherapy to treat bladder cancer and has long-term proven results in intermediate and high-risk patients.
The Synergo System is a computer-embedded intravesical irrigation system combined with an energy-delivering unit. The System includes an RF generator that delivers radio-frequency energy (the lower limit of microwave electromagnetic radiation) at 915 MHz, a drug circulating unit, and a microprocessor with application specific software.
Read more on how the technology works here.
Israel Trade and Economic Commission in Sydney, Australia 